Author Affiliations: University of Chicago, Chicago, Illinois (firstname.lastname@example.org).
To the Editor: Drs Goldenberg and Sharp1 detail the serious and difficult ethical concerns surrounding potential use of genomic technologies in NBS. We agree that these issues must be addressed carefully before proceeding; however, the authors fail to consider conditions for which easy mechanisms for biochemical screening do not currently exist but that could be predicted reliably by gene sequencing.
Greeley SAW, Msall ME, Acharya K. Genomic Sequencing in Newborn Screening Programs. JAMA. 2012;307(20):1911-1912. doi:10.1001/jama.2012.3635